Last reviewed · How we verify
4 weeks of Nicotine lozenge — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
4 weeks of Nicotine lozenge (4 weeks of Nicotine lozenge) — University of Virginia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 4 weeks of Nicotine lozenge TARGET | 4 weeks of Nicotine lozenge | University of Virginia | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 4 weeks of Nicotine lozenge CI watch — RSS
- 4 weeks of Nicotine lozenge CI watch — Atom
- 4 weeks of Nicotine lozenge CI watch — JSON
- 4 weeks of Nicotine lozenge alone — RSS
Cite this brief
Drug Landscape (2026). 4 weeks of Nicotine lozenge — Competitive Intelligence Brief. https://druglandscape.com/ci/4-weeks-of-nicotine-lozenge. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab